LITTLE FALLS, N.J.,
March 5, 2019 /PRNewswire/ -- Cantel
Medical Corp. (NYSE: CMD) today announced that George L. Fotiades has been named the Company's
President and Chief Executive Officer, effective immediately.
Mr. Fotiades also will continue to serve on Cantel's Board of
Directors. He succeeds Jorgen B.
Hansen, who has resigned from the Company and its Board of
Directors.
![(PRNewsfoto/Cantel Medical Corp.) (PRNewsfoto/Cantel Medical Corp.)](https://mma.prnewswire.com/media/778219/Cantel_Logo.jpg)
Mr. Fotiades has over 35 years of experience with companies in
the healthcare and consumer products industries, both as an
operator and an investor. He has been a member of Cantel's
Board of Directors since 2008 and most recently served as Operating
Partner at Five Arrows Capital Partners. Mr. Fotiades was
previously President and COO of Cardinal Health, where he led the
successful acquisition and integration of several businesses,
creating Cardinal's Pharmaceutical Technologies & Services
segment. After the segment's sale to The Blackstone Group in
2007, Mr. Fotiades became Chairman of the new company, which became
Catalent, Inc.
Charles M. Diker, Chairman of the
Cantel Board, said, "On behalf of the Board, I am very pleased to
appoint George as Cantel's new President and CEO. His
experience leading companies through significant growth, creating
organizational capabilities on a global scale, and integrating
acquired businesses make him the ideal candidate to lead Cantel at
this juncture. George has been a key contributor to the Board
for over a decade and will make a seamless transition to this role.
The Board and I look forward to working with George in his new
capacity to support the next phase of Cantel's development."
"Cantel has an excellent market position and many opportunities
ahead for both organic growth and continued acquisition activity,"
said Mr. Fotiades. "I look forward to working with the Board
and the Executive Leadership Team in my new role to improve our
operating model and performance, drive organic growth, attract and
cultivate top leadership talent, and identify attractive
acquisition candidates and expansion opportunities."
Mr. Diker continued, "We thank Jorgen for his many contributions
to Cantel. During Jorgen's tenure, Cantel made significant
progress expanding internationally and completed a number of key
strategic acquisitions that have bolstered our market position and
driven growth. Jorgen is a talented executive of the highest
integrity and we wish him all the best in the next phase of his
career."
Mr. Hansen said, "It has been a privilege to lead the team at
Cantel. During my tenure, we executed on our ambitious strategy,
strengthening Cantel's business and global reach. By doing so, we
have taken the Company's mission of saving lives through infection
prevention to the next level. I am proud of what we have
accomplished together."
Biography of George L.
Fotiades
George L.
Fotiades, 65, has served on the Board of Cantel and a
non-executive member of the Office of the Chairman since April
2008. He most recently served as an Operating Partner at Five
Arrows Capital Partners (FACP), the private equity arm of
Rothschild Merchant Banking, and previously was a Partner at
Diamond Castle Holdings, focusing on healthcare investments.
Mr. Fotiades was Chairman of Catalent Pharma Solutions from 2007 to
2010, after the company was purchased by The Blackstone Group from
Cardinal Health, and served as interim CEO. Prior to that,
Mr. Fotiades served as President and Chief Operating Officer of
Cardinal Health, Inc., and before that he created and led Cardinal
Health's Pharmaceutical Technologies & Services segment.
Earlier in his career, he served in a number of executive roles,
including president of Warner-Lambert's consumer healthcare
business and senior positions at Bristol-Myers Squibb, Wyeth and
Procter & Gamble.
Mr. Fotiades is a director of Prologis, Inc., a leading owner,
operator and developer of industrial real estate, and non-executive
Chairman of the Board of AptarGroup Inc., a leader in the global
dispensing systems industry. He received a Bachelor of Arts
from Amherst College and a Master of
Management from The Kellogg School of Management at Northwestern University.
About Cantel
Cantel is a leading global company
dedicated to delivering innovative infection prevention products
and services for patients, caregivers, and other healthcare
providers which improve outcomes, enhance safety and help save
lives. Our products include specialized medical device reprocessing
systems for endoscopy and renal dialysis, advanced water
purification equipment, sterilants, disinfectants and cleaners,
sterility assurance monitoring products for hospitals and dental
clinics, disposable infection control products primarily for dental
and GI endoscopy markets, dialysate concentrates, hollow fiber
membrane filtration and separation products. Additionally, we
provide technical service for our products.
For further information, visit the Cantel website at
www.cantelmedical.com.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/cantel-medical-names-george-l-fotiades-president-and-ceo-300806611.html
SOURCE Cantel Medical Corp.